Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

Organon

Status and phase: Completed; Phase 3

Conditions: Recurrent Low Back Pain

Treatments: Drug: MK0663, Etoricoxib / Duration of Treatment : 12 Weeks; Drug: Comparator : placebo (unspecified) /Duration of Treatment : 12 Weeks

Study type: Interventional

Funder types: Industry

Identifiers

NCT00393211

0663-042

2006_547

Details and patient eligibility

About

Study the effect of etoricoxib 60 mg and 90 mg compared to placebo to treat chronic low back pain.

Enrollment: 319 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Low back pain for previous 3 months and majority of days in last month
• Regular use of acetaminophen or NSAID to treat low back pain in past month
• Judged to be in otherwise good health

Exclusion criteria

• Low back pain that is due to secondary causes
• Radicular/myelopathic pain
• Surgery for low back pain within the past 6 months
• Active lawsuit or claim pertaining to their low back pain
• Disease that may confound the results of the study or pose risk to the patients
• Corticosteroid use in past month
• Previous participation in an MK0663 study

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind